ABG-WTT Global Life Science Capital Partners GP Ltd — Q4 2024 13F-HR

← ABG-WTT Global Life Science Capital Partners GP Ltd

Q4 2024 · 13F-HR

ABG-WTT Global Life Science Capital Partners GP Ltdholdings as filed

Filed 2025-02-14 · accession 0000950123-25-002368

$43.7M

Reported value

Positions

2024-12-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
15678C102	CBLL	CERIBELL INC	$28.2M	64.4%	1,088,101	Common	SOLE
156944100	CGON	CG ONCOLOGY INC	$14.2M	32.5%	495,526	Common	SOLE
75340L104	RPID	RAPID MICRO BIOSYSTEMS INC	$934,466	2.14%	1,038,296	Common	SOLE
745848101	LUNG	PULMONX CORP	$408,785	0.94%	60,204	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.